- Immune Deficiency Cellular Therapy Program Clinical Research Team🔍
- Immune Deficiency Cellular Therapy Program🔍
- Program for Integrated Immunodeficiency and Cellular Therapy 🔍
- New NIH program provides comprehensive treatment for inherited ...🔍
- Cell Therapy CRT🔍
- Participating in clinical trials🔍
- Cellular Immunotherapy Program🔍
- Sung|Yun Pai🔍
Immune Deficiency Cellular Therapy Program Clinical Research Team
Immune Deficiency Cellular Therapy Program Clinical Research Team
The Immune Deficiency Cellular Therapy Program (ID-CTP) seeks to accelerate progress in the treatment of children, adolescents and young adults with genetic ...
Immune Deficiency Cellular Therapy Program
The Immune Deficiency Cellular Therapy Program (ID-CTP) seeks to accelerate progress in the treatment of children, adolescents and young adults with genetic ...
Program for Integrated Immunodeficiency and Cellular Therapy (PIICT)
Our program participates in several clinical trials investigating gene therapies. We are part of the Primary Immune Deficiency Treatment Consortium studying ...
New NIH program provides comprehensive treatment for inherited ...
People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, ...
Cell Therapy CRT - Yale Cancer Center
To assist in the development, understanding, characterization, and approval of new cellular therapies for the broader research community. Research Team Meetings ...
Participating in clinical trials | Immune Deficiency Foundation
Clinical trials help researchers develop safe, effective treatments and diagnostics for primary immunodeficiency (PI), as well as understand how these ...
Cellular Immunotherapy Program - Massachusetts General Hospital
Our approach is to expand cellular engineering and immunotherapy research by bringing together physicians and laboratory scientists focused on immune cell ...
Sung-Yun Pai, M.D. | Principal Investigators
Our goal is to understand how the genetic cause of severe combined immunodeficiency (SCID) impacts T cell, B cell, and natural killer (NK) cell ...
Gene and Cell Therapy Institute | Mass General Brigham
Maus and her research team design and evaluate next generation genetically modified (CAR) T cells as immunotherapy in patients with cancer. Using the immune ...
Clinical Immunotherapy Program - UNC Lineberger
The process involves extracting specific immune cells from patients, engineering the cells in the lab to hunt tumor cells displaying a specific molecular target ...
Center for Cancer & Immunology Research
This research center works to ensure that personalized cures for cancer, immune disorders and blood diseases are available for every child.
Cell & Gene Therapy | Fred Hutchinson Cancer Center
Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient's own immune cells to fight disease.
Cellular Therapies Program Team - Dana-Farber Cancer Institute
The Cellular Therapies Program team leads clinical care and research of promising cellular therapies across all adult disease centers.
Allergy, Immunology and BMT - Research | Department of Pediatrics
The UCSF Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation is the lead site for the national Primary Immunodeficiency Treatment ...
Hematology, Blood & Marrow Transplant, and Cellular Therapy ...
The UCSF Hematology, Blood and Marrow Transplant, and Cellular Therapy (HBC) Program provides advanced treatment options with care and compassion.
Sarah Cannon Transplant and Cellular Therapy Network
The Sarah Cannon Transplant & Cellular Therapy Network offers patients convenient, community-based access to complex blood cancer care, hematopoietic cell ...
Transplant and Cellular Therapy Program - UT Medical Center
Our treatment options include peripheral blood stem cell transplant, chimeric antigen receptor t-cell (CAR-T) therapies, and clinical trials involving Immune ...
Cellular Therapy Program - Blood & Marrow Transplantation
In the laboratory, a special gene is added to the T cells that enables them to recognize and attack cancer cells. These modified immune cells — now called CAR T ...
Cellular Therapies: Clinical Research Program
Subject is 30 years of age or younger · Epstein-Barr virus infections post allogeneic HSCT, primary immunodeficiencies or post solid organ transplant with:.
Transplantation and Cellular Therapy | Children's Hospital Los ...
Our specialized therapies treat childhood cancer, blood diseases and other rare genetic and immune conditions. Our world-leading research offers these children ...